Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
$60K in pitch competition winnings will help Black-owned businesses drive employment, book purchases
The owner of a mobile phlebotomy company took home the $30,000 grand prize at Friday’s We Are Black pitch competition — the first such event organized by Kansas City G.I.F.T. LaVita Green said the funding and resources from G.I.F.T. will help Caresticks Mobile Phlebotomy, which provides patients with on-site and mobile phlebotomy services, to grow…
Documentaries with KC ties set for FilmFest screens: Here’s when you can see these gripping films in local theaters
Streaming services might have become the standard since the COVID-19 pandemic drove more people to entertain themselves from home, but filmmakers and film enthusiasts are encouraging the community to gather at theaters for the 27th annual Kansas City FilmFest International. “What’s so great about film festivals is that you’re able to see these films months…
Hope starts at home: Economic mobility, inclusion hinge on realities of identity, panel says
Editor’s note: The Junior League of Kansas City — through its C3KC conference — is an advertiser with Startland News. An important step in bridging the wealth gap and building equity is meeting people at their level of readiness, Terrell Jolly shared. “Because if you do not, they will inconvenience you in some kind of way and that’s the sad…
Devoured Pizza rising into brick-and-mortar space with elevated concept, revenue sharing campaign
Devoured Pizza is on a mission to change the way people eat pizza in Kansas City, Jhy Coulter said, and the community has the opportunity to get involved now more than ever. “Food in Kansas City is evolving. It’s getting better and better, and I want to be part of that. Pizza is this canvas…